Aminologics Co.Ltd Cash Flow-to-Debt Ratio
Aminologics Co.Ltd cash flow-to-debt ratio. Aminologics Co.Ltd (074430) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of ₩-255.72 Million could theoretically repay 0% of its total liabilities (₩31.28 Billion) in one year. Check cash flow quality index of Aminologics Co.Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aminologics Co.Ltd (2008–2025)
Cash flow-to-debt ratio of Aminologics Co.Ltd from 2008 to 2025. Historical debt coverage capacity for Aminologics Co.Ltd across 13 annual periods. Check 074430 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Aminologics Co.Ltd Cash Flow-to-Debt Ratio by Year (2008–2025)
Aminologics Co.Ltd cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Aminologics Co.Ltd. For the full cash flow conversion analysis, see Aminologics Co.Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | ₩2.54 Billion | ₩28.18 Billion | ▼ -93.9% |
| 2024 | 1.47x | ₩7.47 Billion | ₩5.09 Billion | ▲ +2288.3% |
| 2023 | -0.07x | ₩-218.15 Million | ₩3.26 Billion | ▼ -105.4% |
| 2022 | 1.25x | ₩5.23 Billion | ₩4.18 Billion | ▲ +682.1% |
| 2021 | 0.16x | ₩935.52 Million | ₩5.85 Billion | ▼ -40.6% |
| 2020 | 0.27x | ₩1.77 Billion | ₩6.57 Billion | ▼ -55.8% |
| 2019 | 0.61x | ₩3.60 Billion | ₩5.92 Billion | ▼ -51.0% |
| 2018 | 1.24x | ₩4.56 Billion | ₩3.67 Billion | ▲ +75.0% |
| 2017 | 0.71x | ₩3.00 Billion | ₩4.23 Billion | ▼ -23.2% |
| 2016 | 0.92x | ₩4.14 Billion | ₩4.48 Billion | ▲ +223.5% |
| 2015 | 0.29x | ₩1.93 Billion | ₩6.75 Billion | ▲ +193.8% |
| 2014 | -0.30x | ₩-2.07 Billion | ₩6.78 Billion | ▼ -134.4% |
| 2008 | 0.89x | ₩12.19 Billion | ₩13.77 Billion | — |